Chargement en cours...
Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy
A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy, presented in refractory cardiogenic shock requiring inotropic therapy. Given his wishes to die without having any intravenous medications, he was started on oral probene...
Enregistré dans:
| Publié dans: | JACC Case Rep |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301499/ https://ncbi.nlm.nih.gov/pubmed/34316787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2019.07.008 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|